BioTherapeutics is committed to developing therapies with the aim of saving and sustaining lives. Our aim is to provide the highest quality products and programs that advance patient care globally and enable the achievement of outcomes through innovation, science, and technology.
The BioTherapeutics' team specializes in three key therapeutic areas: immunoglobulins, pulmonology, and critical care therapies. BioTherapeutics' immunoglobulin therapies treat primary immunodeficiencies associated with defects in humoral immunity or a lack of antibody production. BioTherapeutics also produces antibody-replacement therapies to bolster the immune system of people with secondary immunodeficiencies and recurrent infections. Immunoglobulin therapies also include treatments for ITP in patients with low platelet counts.
Read More [+]
CINCINNATI – Cincinnati Children’s Hospital Medical Center today dedicates the opening of a Jeffrey Modell Foundation (JMF) Diagnostic Center for Primary Immunodeficiencies, one of only 55 of its kind in the world and only 31 in the United States.
The Center will be dedicated during a ceremony at noon today at the Cincinnati Children’s main campus in Avondale. The Diagnostic Center focuses on the diagnosis, care, and treatment of children suffering with Primary Immunodeficiency (PI).
Read More [+]
A sterile, nonpyrogenic preparation of albumin in a single-dosage
Sterile, stable, lyophilized preparation of purified alpha 1-proteinase inhibitor
